NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea · Delayed Price · Currency is KRW 1,845.00
-110.00 (-5.63%)
Sep 22, 2026, 3:30 PM KST
NeoImmuneTech Market Cap
NeoImmuneTech has a market cap or net worth of 193.29 billion as of September 22, 2026. Its market cap has decreased by -54.75% in one year.
Market Cap
193.29B
Enterprise Value
157.29B
Revenue
1.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,845.00
ChartMarket Cap Chart
Since March 16, 2021, NeoImmuneTech's market cap has decreased from 7.32T to 193.29B, a decrease of -97.36%. That is a compound annual growth rate of -48.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 182.41B | -55.05% |
| Dec 30, 2025 | 405.85B | -27.02% |
| Dec 30, 2024 | 556.13B | -44.44% |
| Dec 28, 2023 | 1.00T | -49.29% |
| Dec 29, 2022 | 1.97T | -61.23% |
| Dec 30, 2021 | 5.09T | -30.48% |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDIPOST | 346.69B |
| SillaJen | 306.90B |
| Genomictree | 293.56B |
| Bioneer | 227.65B |
| GC Cell | 213.84B |
| HLB Therapeutics | 177.16B |
| GC Genome | 163.19B |
| Anterogen.Co.,Ltd. | 151.49B |